1,3-dicapryloylglycerol has been researched along with tipranavir in 1 studies
Studies (1,3-dicapryloylglycerol) | Trials (1,3-dicapryloylglycerol) | Recent Studies (post-2010) (1,3-dicapryloylglycerol) | Studies (tipranavir) | Trials (tipranavir) | Recent Studies (post-2010) (tipranavir) |
---|---|---|---|---|---|
8 | 0 | 0 | 289 | 42 | 47 |
Protein | Taxonomy | 1,3-dicapryloylglycerol (IC50) | tipranavir (IC50) |
---|---|---|---|
Protease | Human immunodeficiency virus 1 | 0.03 | |
CAAX prenyl protease 1 homolog | Mus musculus (house mouse) | 1.2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, S; Darrington, RT; Dudhedia, MS; Jones, PJ; Krill, SL; Smoliga, JA; Tamblyn, T; Wang, Z | 1 |
1 other study(ies) available for 1,3-dicapryloylglycerol and tipranavir
Article | Year |
---|---|
Drug-excipient complexation in lipid based delivery systems: an investigation of the Tipranavir-1,3-dioctanolyglycerol complex.
Topics: Algorithms; Anti-HIV Agents; Calorimetry, Differential Scanning; Chromatography, High Pressure Liquid; Diglycerides; Drug Delivery Systems; Lipids; Magnetic Resonance Spectroscopy; Nonlinear Dynamics; Pyridines; Pyrones; Solubility; Solvents; Sulfonamides; Surface-Active Agents; X-Ray Diffraction | 2009 |